Avai Bio, Inc.
AVAI· OTC
Filed Jul 14, 2026 · 10-K · 105 days after period end · 0001740797-26-000017
derived · Computed from the longer spans the company filed.
| Metric | Q4 2026dderived from reported figures | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$255.18K | $462.07K | -$303.43K | $15.73K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed Jul 14, 2026 · 105 d after period end